Main Street Group’s Novartis NVS Stock Holding History

Main Street Group’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.64K	Hold	36	–	–	﹤0.01%	628
2026 Q1	$5.5K	Buy	+36	New	+$5.52K	﹤0.01%	617
2025 Q4	–	Sell	-36	Closed	-$4.62K	–	430
2025 Q3	$4.62K	Hold	36	–	–	﹤0.01%	624
2025 Q2	$4.36K	Sell	36 -62	-63%	-$6.99K	﹤0.01%	591
2025 Q1	$10.9K	Hold	98	–	–	﹤0.01%	487
2024 Q4	$9.54K	Hold	98	–	–	﹤0.01%	494
2024 Q3	$11.3K	Buy	98 +36	+58%	+$4.08K	﹤0.01%	479
2024 Q2	$6.61K	Hold	62	–	–	﹤0.01%	589
2024 Q1	$5.94K	Hold	62	–	–	﹤0.01%	630
2023 Q4	$6.26K	Buy	+62	New	+$5.98K	﹤0.01%	916

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Main Street Group's NVS Position: Q2 2026 in Review

Main Street Group held its Novartis (NVS) position steady in Q2 2026 at 36 shares worth $5.64K. The position accounts for ﹤0.01% of the portfolio, ranked #628.

Main Street Group first reported a position in NVS in Q4 2023 and has held it in 10 quarters since. The position peaked at $11.3K in Q3 2024. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Main Street Group held 36 shares of Novartis worth $5.64K as of Q2 2026.
Main Street Group left its Novartis share count unchanged in Q2 2026.
Novartis made up ﹤0.01% of Main Street Group's portfolio in Q2 2026, its #628 holding.
Main Street Group first reported a position in Novartis in Q4 2023 and has held it in 10 quarters since.
Main Street Group's Novartis position peaked at $11.3K in Q3 2024.
1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Main Street Group's 13F filing for Q2 2026, filed 13 Jul 2026.